Home › NDC Lookup › Ingredients › Guaifenesin And Dextromethorphan Hbr › 59651-0069-82
⚪image loading
(from DailyMed)

Guaifenesin and Dextromethorphan HBr 1200 mg; 60 mg Tablet, Extended Release, 800-count

by Aurobindo Pharma Limited · 800 TABLET, EXTENDED RELEASE in 1 BAG (59651-069-82)
NDC 59651-0069-82
🏷️ FDA NDC (as labeled) 59651-069-82 billing pads the product segment with a zero
On market Non-controlled
🗂️ Data synced Aug 20, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 59651-069-82
Product NDC 59651-069
11-digit billing NDC 59651006982
SPL Set ID 2c0c6337-607a-4ca3-821e-d80ea2fe19b9
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2017-03-17
Dosage form TABLET, EXTENDED RELEASE
Substance GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
Why two NDCs? The FDA registers this code as 59651-069-82 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 59651-0069-82. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerAurobindo Pharma Limited
Labeler code59651
First marketedMar 2017
Product typeDrug For Further Processing
Portfolio1,452 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an extended-release tablet combining two active ingredients commonly used in over-the-counter cough and cold products. Guaifenesin is typically used as an expectorant to help thin mucus and make coughs more productive. Dextromethorphan hydrobromide is a cough suppressant commonly used to reduce coughing. This listing is marked as a drug for further processing, meaning it is a bulk or intermediate product intended for use in manufacturing other drug products rather than for direct consumer use.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

We could not link this NDC to a current FDA Structured Product Label. An inactive-ingredient list is therefore not available from this source.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Guaifenesin And Dextromethorphan Hbr 1200 mg/1; 60 mg 30142-0963-14 Kroger 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 41415-0999-14 PUBLIX 14 tablets — — FDA listed —
Mucus Relief DM 1200 mg/1; 60 mg 60000-0057-65 Ahold 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 63304-0110-54 SUN 14 tablets — — FDA listed —
Mucus Relief DM Expectorant and Cough Suppressant Maximum Strength 1200 mg/1; 60 mg 67091-0315-14 Winco 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 85766-0046-28 Sportpharm 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 65162-0039-03 Amneal 30 tablets — — FDA listed —
Maximum Strength Mucus DM Extended Release 1200 mg/1; 60 mg 69842-0059-10 CVS 7 tablets — — FDA listed —
Mucus Relief DM MAXIMUM STRENGTH 1200 mg/1; 60 mg 21130-0989-03 Better 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 1200 mg/1; 60 mg 43598-0232-37 Dr. 14 tablets — — FDA listed —
Maximum Strength Mucus Relief DM 1200 mg/1; 60 mg 49035-0956-61 Wal-Mart 28 tablets — — FDA listed —
Mucus DM 1200 mg/1; 60 mg 46122-0420-03 Amerisource 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 58602-0849-11 Aurohealth 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 1200 mg/1; 60 mg 43598-0115-28 Dr. 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 30142-0275-05 KROGER 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 58602-0825-06 Aurohealth 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 71179-0011-21 VESPYR 7 tablets — — FDA listed —
Mucus Relief DM 1200 mg/1; 60 mg 72036-0980-65 Harris 7 tablets — — FDA listed —
Guaifenesin And Dextromethorphan Hbr 1200 mg/1; 60 mg 76162-0032-56 TOPCO 7 tablets — — FDA listed —
Maximum Strength Cough And Congestion Extended Release 1200 mg/1; 60 mg 51316-0060-65 CVS 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 51660-0110-54 OHM 14 tablets — — FDA listed —
Members Mark Mucus Relief DM 1200 mg/1; 60 mg 68196-0999-56 SAM'S 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mgthis 59651-0069-82 Aurobindo 800 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 58602-0715-05 Aurohealth 14 tablets — — FDA listed —
Maximum Strength Mucus Relief DM 1200 mg/1; 60 mg 00363-0510-65 WALGREEN 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 11673-0267-05 Target 14 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2017
On the market since
Mar 2017
📍
2026
Currently FDA-listed
9 years listed
🔒
·
Generic approved (availability unconfirmed)
see note
🔒Generic approved by FDA, but pharmacy availability is not confirmed

The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
59651-0069-82 You're viewing this 800 TABLET, EXTENDED RELEASE in 1 BAG (59651-069-82) — Active

🧭 About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Aurobindo Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 59651-069-82, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 59651-0069-82, written without dashes as 59651006982. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 59651-0069-82, the first segment (59651) is the labeler code FDA assigned to Aurobindo Pharma Limited; the middle segment (0069) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (82) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aurobindo Pharma Limited. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Aurobindo Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 59651-0068-15 · Aurobindo 59651-0072-82 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.